Health & life sciences
Doctors and patients may each see only what the rules allow.
For pharma and biotech companies, from branded generics to clinical research, we build HCP portals, claims libraries and journeys for patient support and trial recruitment. AI drafts from approved sources, and your medical, legal and regulatory reviewers sign off.
Where the rules biteMap of all forty-one industries
What is shifting
A national marketing code, pack verification codes, revised manufacturing rules and US action on drug advertising. Each lists what it demands, with a dated source.
What it requiresHCP journeys, events and samples designed to the code, with every interaction recorded.
EvidenceThe Department of Pharmaceuticals notified the Uniform Code for Pharmaceutical Marketing Practices on 12 March 2024, covering gifts, travel, samples and medical education.
What it requiresPack designs with room for codes, and patient journeys that explain how to check them.
EvidenceSince 1 August 2023, the 300 drug brands listed in Schedule H2 must carry a barcode or QR code that lets anyone verify the product.
What it requiresQuality systems, documentation and supplier portals ready for inspection.
EvidenceRevised Schedule M, notified on 28 December 2023, applied to larger firms from mid-2024 and to smaller firms granted extensions by 31 December 2025.
What it requiresFair-balance risk information and disclosed influencer content in every market you promote in.
EvidenceOn 9 September 2025 the US FDA announced thousands of letters to drug sponsors and about 100 cease-and-desist letters over misleading advertising.
The rulebook
India’s drug-advertising law and marketing code, plus the clinical-trial, manufacturing, data and cyber rules, summarised for a typical programme. Your medical, legal and regulatory reviewers keep sign-off.
Frameworks we build to
We design and build to these frameworks; this is not a claim of certification.
Shapes most of the work
Department of Pharmaceuticals
Promotion to healthcare professionals must be evidence-based and balanced; gifts, travel and hospitality for HCPs are barred, samples are limited, and complaints go to an ethics committee.
We designHCP programmes are designed without inducements, with evidence on every message and interactions recorded.
Department of Pharmaceuticals · UCPMP, notified 12 March 2024 Official text: Uniform Code for Pharmaceutical Marketing Practices, 2024
Shapes most of the work
Government of India
Bars advertising that promises to cure, prevent or treat the diseases and conditions in its Schedule, and claims of magic remedies, in any medium.
We designA blocked-claims list built from the Schedule runs on every draft, human or AI.
Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
CDSCO, Ministry of Health
Trials run with CDSCO permission, ethics-committee approval and informed consent, with compensation for trial-related injury or death.
We designRecruitment pages and consent materials are designed in plain language and for ethics-committee review.
New Drugs and Clinical Trials Rules, 2019 (notified 19 March 2019)
Ministry of Health · CDSCO
An upgraded GMP standard for every plant: a pharmaceutical quality system, quality risk management, product quality reviews and validated computerised systems, with stronger data integrity.
We designQuality and supplier portals are built with audit trails and data-integrity controls from the start.
Drugs Rules, 1945 · revised Schedule M, G.S.R. 922(E), 28 December 2023
Ministry of Health · CDSCO
Makers of the 300 brands in Schedule H2 print a barcode or QR code on the label holding the product code, generic and brand names, maker, batch, dates and licence number.
We designPack layouts keep a fixed space for the code, and patient pages explain how to check it.
Drugs Rules, 1945 · Schedule H2, G.S.R. 823(E), 17 November 2022 (from 1 August 2023)
Shapes most of the work
Ministry of Electronics and IT
Patient-support, trial and HCP data collected per purpose with consent, withdrawal as easy as consent, and breach reporting to the Data Protection Board.
We designPatient programmes ask only for what support needs, with consent logged per purpose.
DPDP Act, 2023 · DPDP Rules, 2025 (core obligations from 13 May 2027) Official text: DPDP Act, 2023 and DPDP Rules, 2025
Often shapes the work
Indian Computer Emergency Response Team
Cyber incidents reported to CERT-In within six hours of being noticed, and ICT logs kept for 180 days.
We designPortals and platforms launch with logging, monitoring and an incident runbook built for the six-hour deadline.
CERT-In · Directions under section 70B(6), 28 April 2022 Official text: CERT-In Directions, 2022
Compiled 3 October 2026. Our reading of typical programmes, not legal advice. Rules change; your counsel confirms how each one applies to you.
Challenges
What comes up first in most pharma & biotech conversations, from customer-facing screens to internal operations.
HCPs want clinical evidence and prescribing information quickly, without a sales visit.
Adherence, access and side-effect information in plain words, in their own language.
Eligibility, sites and consent explained clearly enough for patients to decide.
What we build
A typical programme here uses each discipline in this mix. Each line says what it builds for the industry and links to the capability behind it.
Claims libraries, review workflows and secure portals integrated with your CRM and safety systems.
HCP and patient content produced from an approved claims library, ready for medical-legal review.
Brand and pack designs with space for declarations and codes, and a clear portfolio architecture.
Drafting and medical-information assistants that cite approved sources and route possible adverse events.
HCP portals, patient-support programmes and trial-recruitment journeys designed for clarity and consent.
Consented HCP engagement and omnichannel journeys, recorded the way the marketing code expects.
Programmes
The diagnostic ranks fixes by review time and risk, and records your baseline. Each later programme has its own agreed measure. Durations are typical, not promised.
The way in
We map every claim, channel and approval step against the advertising law and marketing code, and show where review stalls and risk sits.
What you get
02Project · 8–12 weeks
Approved claims, references and expiry dates in one library, with a review workflow that runs medical, legal and regulatory checks in parallel.
MeasureShare of assets approved first time
Services: Workflow automation · Content model & headless CMS · Brand check
Enquire about Claims library and review workflow03Milestone · 4–9 months
A portal for healthcare professionals and a patient-support journey, each showing only what its audience may receive, with consent and safety reporting built in.
MeasureHCP portal engagement with prescribing information
Services: Complete UX & UI design · Custom CRM or operations platform · Lifecycle journey build
Enquire about HCP portal and patient-support programme04Project · 8–12 weeks
An assistant that answers from approved medical information, cites its source and routes any possible adverse event to pharmacovigilance.
MeasureAnswer accuracy on an agreed evaluation set
Services: AI knowledge assistant · AI assistant experience design
Enquire about Medical-information assistant with evaluationsHow success is measured
Main measureTime from brief to medical-legal approval
AI, under the rules
Each use has an owner, an evaluation set and a log, and any possible adverse event goes to your pharmacovigilance team.
Use case 01
Measured byShare of drafts approved without changes
Tested forOWASP LLM09 · Misinformation
Goes live only with its evaluation set, automatic checks and a named owner
Use case 02
Measured byAnswer accuracy on an agreed evaluation set
Tested forOWASP LLM01 · Prompt injection
Goes live only with its evaluation set, automatic checks and a named owner
Use case 03
Measured byReports routed within the agreed time
Tested forOWASP LLM02 · Sensitive information disclosure
Goes live only with its evaluation set, automatic checks and a named owner
Work and insights
No pharma & biotech client is named or described without written approval. Here is what we have written that bears on the industry.
A typical programme · composite
A speciality pharma company moved its HCP content into a claims library that records each statement’s reference, approval and expiry. Field teams, the HCP portal and medical education now use the same approved words.
Anonymised and illustrative: the shape a programme takes, never a named client.
Nothing published on pharma & biotech yet. Ask us what we are seeing in the industry.
Ask usQuestions
Something else on your mind? Ask us directly
Yes. Our portals verify the healthcare professional before showing promotional or prescribing content, keep patient material separate and record the interactions the marketing code requires.
We route them to your pharmacovigilance team with the original message attached. Every form, chat and social-listening channel we build has this route, working within the time your procedures set.
It drafts, but only from your approved claims library. Your medical, legal and regulatory reviewers approve every asset before it is used.
Yes. We build B2B brands, capability sites, quality and supplier portals and RFQ journeys for CDMOs and API makers, where buyers judge inspection readiness and data integrity.
Keep exploring
You will speak to a lead who would run the work, and get a straight answer on fit.
01About 2 minutes
You get A reply from a named lead
02About 8 minutesRecommended
You get Options and a first scope after one call
03About 15 minutes
You get Receipt confirmed and a named bid lead
Every engagement starts with a written scope and a quote agreed before work begins. How each package is priced
